Company intelligence / Profile preview

Shenzhen Capital Group

Shenzhen, Guangdong, China

Ownership: Private
Development stage: Other

Overview

Shenzhen Capital Group is a leading Chinese state-owned venture capital and private equity investor focused on innovative high-tech sectors, notably with significant activity in life sciences, healthcare, biotechnology, and health-related investments. It does not itself develop drugs or clinical assets, but invests in and empowers portfolio companies in those domains[1][3][4][5][6].

Industry: Investors

Partnerships

Numerous partnerships with portfolio companies (e.g., Accropeutics, investments in biotech and pharma)

Beyond the preview

Go deeper on Shenzhen Capital Group.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Shenzhen Capital Group.

Explore the full profile